as on December 1, 2025 at 2:33 pm IST
Day's Low
Day's High
0.34%
Downside
6.32%
Upside
52 Week's Low
52 Week's High
31.37%
Downside
21.22%
Upside
as on December 1, 2025 at 2:33 pm IST
Market Cap
₹1,754.78 Cr
Return on Equity (ROE)
6.74
PE Ratio (TTM)
15.96
Return on capital employed (ROCE)
9.16
Industry PE ratio
42.13
Beta (LTM)
1.16
P/B Ratio
1.17
Dividend Yield
0.43
PEG Ratio
3.66
Quarterly Earnings Growth YOY
11.29
EPS (TTM)
8.57
Sector
Pharmaceuticals
Book Value
99.68
Technical Analysis
Bearish
View Technical Analysis
as on December 1, 2025 at 2:33 pm IST
Bliss Gvs in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (15.96x)
November 28, 2025
Industry (42.13x)
November 28, 2025
Highest (576.11x)
January 3, 2022
Today’s Price to Earnings Ratio: 15.96x
Compare market cap, revenue, PE, and other key metrics of Bliss Gvs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,754.78 | -0.45% | 0.56 | 90 | 809 | |
| NA | 84.12 | -10.98% | 0.00 | 10 | 40 | |
| NA | 15.00 | 36.6% | 0.00 | -2 | 5 | |
| NA | 44.21 | -16.21% | 0.70 | 6 | 318 | |
| HOLD | 2,362.93 | -0.9% | 0.75 | -78 | 1,664 |
Investment in Bliss GVS Pharma Ltd Shares on INDmoney has grown by 287.60% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:287.60% versus previous 30 day period
Search interest for Bliss GVS Pharma Ltd Stock has increased by 213% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:213% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Bliss Gvs.
Bliss GVS Pharma Ltd’s net profit jumped 12.32% since last year same period to ₹27.25Cr in the Q2 2025-2026. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -36.69% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 per share on 12 May 2025 - translating a dividend yield of 0.30%.
Read More about DividendsCheck stock indices that include Bliss Gvs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, BLISSGVS stock has moved up by 6.9%
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 210.05 Cr → 264.58 Cr (in ₹), with an average increase of 10.9% per quarter
Best in 3 Years
![]()
In the last 3 years, BLISSGVS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
FII Holding Up
![]()
Foreign Institutions have increased holdings from 12.65% to 13.27% in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Torrent Pharmaceuticals Ltd has given 11.4% return, outperforming this stock by 12.6%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 45.36% of holdings in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 43.04 Cr → 27.25 Cr (in ₹), with an average decrease of 36.7% per quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 35.44% to 35.39% in Sep 2025 quarter
| Organisation | Bliss GVS Pharma Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Subramanian R Vaidya |
| E-voting on shares | Click here to vote |
Bliss Gvs share price today stands at ₹157.54 as on . Bliss Gvs share today touched a day high of ₹167.5 and a low of ₹157.
Bliss Gvs touched a 52 week high of ₹190.97 and a 52 week low of ₹108.12. Bliss Gvs share price today i.e. is trending at ₹157.54, which is -17.51% down from its 52 week high and 45.71% up from its 52 week low.
Bliss Gvs market capitalisation is ₹1,754.78 Cr as on .
To buy Bliss Gvs shares, you need to follow these steps:
Bliss Gvs trading volume is 6.94L as on . This means that 6.94L shares of Bliss Gvs were bought and sold on the stock market during today's trading session.